Symbiotec Pharmalab IPO GMP
Symbiotec Pharmalab IPO was a Mainboard book-built issue of ₹1,757 crore, comprising a Fresh Issue of ₹150 crore and an Offer for Sale of ₹1,607 crore. The price band was ₹938 to ₹988 per share, with a lot size of 15 shares.
Symbiotec Pharmalab IPO GMP Today
Day-wise grey market premium. Est. listing = price cap (₹988) + GMP.
| GMP Date | GMP (₹) | Sub2 (₹) | Kostak (₹) | Est. Listing (₹) | Est. Gain |
|---|---|---|---|---|---|
| August 27, 2026 | 282 | 0 | 0 | ₹1270 | +28.5% |
| August 26, 2026 | 290 | 0 | 0 | ₹1278 | +29.4% |
| August 25, 2026 | 330 | 0 | 0 | ₹1318 | +33.4% |
| August 24, 2026 | 370 | 0 | 0 | ₹1358 | +37.4% |
| August 23, 2026 | 380 | 0 | 0 | ₹1368 | +38.5% |
| August 22, 2026 | 370 | 0 | 0 | ₹1358 | +37.4% |
| August 21, 2026 | 310 | 0 | 0 | ₹1298 | +31.4% |
| August 20, 2026 | 240 | 0 | 0 | ₹1228 | +24.3% |
| August 19, 2026 | 170 | 0 | 0 | ₹1158 | +17.2% |
GMP → Listing Price Calculator
Enter a GMP to estimate listing price, gain and profit per lot. A math estimate only.
Symbiotec Pharmalab IPO Details
See the full Symbiotec Pharmalab IPO details & review →
What is Symbiotec Pharmalab IPO GMP?
Symbiotec Pharmalab IPO GMP refers to the unofficial premium at which the IPO shares were reportedly being quoted in the grey market before listing. It is not an official stock-exchange price and should not be treated as a guaranteed indicator of the actual listing price.
What was the Final GMP?
The latest reported GMP on August 27, 2026 was approximately ₹282 against the ₹988 upper price band, indicating an unofficial estimated price of around ₹1,270.
What was the Expected Listing Price?
Based on a reported GMP of ₹282 and the upper issue price of ₹988, the unofficial estimated listing price was approximately ₹1,270. This was only a grey-market indication and not an official exchange price.
